Juanoltus Expectorante (Dry Extract Of Hederae Folium (Der 4-8:1), Extracting Agent: Ethanol 30 % (M/M))

The extract contains saponins that stimulate bronchial gland secretion and act as mucolytics, increasing the volume of thin airway fluid while lowering mucus viscosity. This facilitates the mechanical removal of secretions during coughing.

The appropriate dose is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and local guidelines. Patients should follow the prescriber’s instructions and the product label.

Safety data in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with synthetic mucolytics, Juanoltus Expectorante offers a plant‑based option with saponin‑driven secretion enhancement. Its safety profile is generally mild, but efficacy may vary; clinicians often consider patient preference, tolerability and specific clinical context when choosing between herbal and conventional expectorants.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and extreme temperatures to maintain stability and potency.

Juanoltus Expectorante is taken orally, usually as a tablet, capsule or liquid preparation, as directed by the prescriber. It should be swallowed with water and may be taken with or without food, depending on the label instructions.

Serious but rare risks include allergic reactions such as rash, angioedema or anaphylaxis, bronchospasm in susceptible individuals, and hepatic enzyme elevations. Any signs of severe hypersensitivity or unexpected symptoms should prompt immediate medical evaluation.

Individuals with known hypersensitivity to Hedera helix leaf extract or any excipients should avoid the product. Patients with severe uncontrolled asthma, COPD exacerbations, or those taking conflicting mucolytic or anticholinergic agents should consult a healthcare professional before use.